CONCURRENT LIPID-LOWERING THERAPY WITH HMG-COA REDUCTASE INHIBITORS REDUCES THE INCIDENCE OF ISHLT GRADES 3A AND 3B REJECTION IN CARDIAC TRANSPLANT RECIPIENTS
R. Sangrigoli et Hj. Eisen, CONCURRENT LIPID-LOWERING THERAPY WITH HMG-COA REDUCTASE INHIBITORS REDUCES THE INCIDENCE OF ISHLT GRADES 3A AND 3B REJECTION IN CARDIAC TRANSPLANT RECIPIENTS, Circulation, 96(8), 1997, pp. 2061-2061